Nimbus Therapeutics Company
Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.
Investors
Connections from
Founded Date:
2009-01-01
Total Funding:
427000000.0
Employee Number:
11-50
Funding Status:
M&A
Technology:
Alternative Medicine, Biotechnology, Health Care, Therapeutics
Last Funding Type:
Venture - Series Unknown
Investors Number:
17.0
Last Funding Date:
2022-09-12
Industry:
End-to-End Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
$1M to $10M